. Author manuscript; available in PMC: 2011 Apr 4.

Published in final edited form as: J Neurophysiol. 2005 Sep 14;94(6):4387–4400. doi: 10.1152/jn.00553.2005

TABLE 1.

Gabazine-induced changes in median onset latency

	L2/3		L4
	Control, ms	Deprived, ms	Control, ms	Deprived, ms
No gabazine
D1	18(24)	17(65)	15.5(16)	15(23)
D2	12(60)	18(70)	10(41)	10(51)
With gabazine
D1	16.5(24)^*	14(65)^**	14(16)	15(23)
D2	11(60)^**	15.5(70)^***	9(41)	10(51)^†

P < 0.005,

^**

P < 0.0001, and

^***

P < 0.0005 relative to no-gabazine condition, Wilcoxon test.

^†

P < 0.01, Wilcoxon test, relative to no-gabazine condition. This significant difference reflects a small but consistent decrease in latency with gabazine, with mean onset latency decreasing from 12.3 ms before gabazine to 11.4 ms during gabazine (P < 0.05, using paired t-test).